Hidenori Fukuoka
Overview
Explore the profile of Hidenori Fukuoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nagano K, Motomura Y, Bando H, Yamamoto M, Kanie K, Yoshino K, et al.
Hormones (Athens)
. 2024 Apr;
23(4):675-681.
PMID: 38625626
Introduction: Levels of serum selenium (Se) and zinc (Zn) decrease when total parental nutrition (TPN) is administered without trace element supplementation for just a few weeks. These trace elements are...
12.
Kanzawa M, Kanda T, Fukuoka H, Shigemura K, Nakamura Y, Itoh T
JCEM Case Rep
. 2024 Apr;
2(4):luae058.
PMID: 38623530
Adrenal cysts lined by thyroid follicular epithelium are rare, with only 14 reported cases of "ectopic thyroid tissue" to date. While the primary consideration for differential diagnosis is thyroid carcinoma...
13.
Bando H, Yamamoto M, Urai S, Motomura Y, Sasaki Y, Ohmachi Y, et al.
J Immunother Cancer
. 2024 Feb;
12(2).
PMID: 38418395
Immune checkpoint inhibitor (ICI)-related hypophysitis (RH) is a common immune-related adverse event. The early detection of ICI-RH prevents life-threatening adrenal insufficiency. However, good predictors of secondary adrenal insufficiency in ICI-RH...
14.
Kanzawa M, Shichi H, Kanie K, Yamamoto M, Yamamoto N, Tsujimoto Y, et al.
Endocrinology
. 2024 Feb;
165(4).
PMID: 38340329
Context: Corticotrophs are susceptible to lymphocyte cytotoxicity, as seen in hypophysitis, suggesting that an immunological approach may be a potential strategy for corticotroph-derived tumors. Objective: We aimed to clarify whether...
15.
Kidawara Y, Kakutani-Hatayama M, Fukuoka H, Koyama H
JCEM Case Rep
. 2024 Feb;
2(2):luae015.
PMID: 38304012
Surgical treatment is generally the standard therapeutic regimen used for primary bilateral macronodular adrenal cortical disease (PBMACD). However, in cases for which surgery is difficult or in which there is...
16.
Motomura Y, Urai S, Hirota Y, Takegawa N, Bando H, Yamamoto M, et al.
Diabetol Int
. 2024 Jan;
15(1):130-134.
PMID: 38264226
We present a case of type 1 diabetes mellitus (T1DM) that developed in a 53-year-old man after long-term treatment with nivolumab. The patient underwent total gastrectomy for gastric cancer at...
17.
Ohmachi Y, Yamamoto M, Inaba Y, Makino S, Urai S, Matsumoto R, et al.
Endocrine
. 2024 Jan;
84(2):694-703.
PMID: 38206436
Purpose: Preoperative medical management is critical to prevent intraoperative cardiovascular complications in patients with pheochromocytomas and paragangliomas (PPGLs). Initial treatment involves α-adrenergic receptor blockers. However, while the routine use of...
18.
Urai S, Iguchi G, Kanie K, Bando H, Yamamoto M, Oi Y, et al.
Eur J Endocrinol
. 2023 Dec;
190(1):K1-K7.
PMID: 38146732
The pathogenesis of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis was gradually revealed as cases emerged. Our comprehensive analysis, including all reported cases, identified a new instance of anti-PIT-1 hypophysitis postimmune checkpoint...
19.
Urai S, Watanabe M, Bando H, Motomura Y, Yamamoto M, Tachihara M, et al.
Front Immunol
. 2023 Nov;
14:1284301.
PMID: 38035072
Introduction: A recently discovered facet of paraneoplastic adrenocorticotropic hormone (ACTH) deficiency exists in two forms: a paraneoplastic spontaneous isolated ACTH deficiency (IAD) and an immune checkpoint inhibitor (ICI)-related hypophysitis. Autoantibodies...
20.
Urai S, Yamamoto M, Yamamoto N, Suzuki M, Shichi H, Kanie K, et al.
Pituitary
. 2023 Nov;
27(1):33-43.
PMID: 37999819
Purpose: Predicting the therapeutic effects of first-generation somatostatin receptor ligands (fg-SRLs) is important when assessing or planning effective treatment strategies in patients with acromegaly. The oft-used maximum growth hormone (GH)...